Your browser doesn't support javascript.
loading
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer.
Liu, Jing; Blake, Stephen J; Harjunpää, Heidi; Fairfax, Kirsten A; Yong, Michelle C R; Allen, Stacey; Kohrt, Holbrook E; Takeda, Kazuyoshi; Smyth, Mark J; Teng, Michele W L.
Afiliación
  • Liu J; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Her
  • Blake SJ; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Harjunpää H; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Fairfax KA; The Walter and Eliza Hall Institute of Medical Research, Molecular Medicine Division, Melbourne, Australia. The Department of Experimental Medicine, University of Melbourne, Parkville, Victoria, Australia.
  • Yong MC; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Allen S; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Kohrt HE; Division of Oncology, Department of Medicine, Stanford University, Stanford, California.
  • Takeda K; Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
  • Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Teng MW; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Her
Cancer Res ; 76(18): 5288-301, 2016 09 15.
Article en En | MEDLINE | ID: mdl-27503925
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Depleción Linfocítica / Modelos Animales de Enfermedad / Inmunoterapia / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Depleción Linfocítica / Modelos Animales de Enfermedad / Inmunoterapia / Neoplasias Experimentales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Res Año: 2016 Tipo del documento: Article